
Transforming CIN Treatment: Innovations and Breakthroughs
Share
The article published in Pharmacy Times by Sam Deutsch, PhD and Nicole Fay, PhD, discusses the urgent need for better therapies to treat cervical intraepithelial neoplasia (CIN) to prevent cervical cancer, highlighting that current treatments are invasive and can have significant side effects. Despite advancements in prevention, such as HPV vaccination, cervical cancer incidence rates are rising among young adults in the U.S. Promising new therapies under development include adjuvant vaccination, topical treatments like imiquimod and fluorouracil, and innovative mRNA therapies. These treatments aim to provide less invasive and more effective alternatives to traditional surgical methods. The White House Initiative on Women’s Health Research is part of broader efforts to address these gaps, with a focus on scientific breakthroughs and enhancing prevention, detection, and treatment of women's health issues. The article underscores the potential for significant improvements in CIN and cervical cancer treatment options in the coming years. Read more here.